Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D

被引:209
作者
Madden, Jeanne M. [1 ,2 ]
Graves, Amy J. [1 ,2 ]
Zhang, Fang [1 ,2 ]
Adams, Alyce S. [1 ,2 ]
Briesacher, Becky A. [3 ,4 ]
Ross-Degnan, Dennis [1 ,2 ]
Gurwitz, Jerry H. [3 ,4 ]
Pierre-Jacques, Marsha [1 ,2 ]
Safran, Dana Gelb [5 ,6 ]
Adler, Gerald S. [7 ]
Soumerai, Stephen B. [1 ,2 ]
机构
[1] Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02215 USA
[2] Harvard Pilgrim Hlth Care, Boston, MA 02215 USA
[3] Univ Massachusetts, Sch Med, Div Geriatr Med, Worcester, MA USA
[4] Univ Massachusetts, Sch Med, Meyers Primary Care Inst, Worcester, MA USA
[5] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA
[6] Blue Cross & Blue Shield Massachusetts, Boston, MA USA
[7] Ctr Medicare & Medicaid Serv, Off Res Dev & Informat, Baltimore, MD USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2008年 / 299卷 / 16期
关键词
D O I
10.1001/jama.299.16.1922
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Cost- related medication nonadherence ( CRN) has been a persistent problem for individuals who are elderly and disabled in the United States. The impact of Medicare prescription drug coverage ( Part D) on CRN is unknown. Objective To estimate changes in CRN and forgoing basic needs to pay for drugs following Part D implementation. Design, Setting, and Participants In a population- level study design, changes in study outcomes between 2005 and 2006 before and after Medicare Part D implementation were compared with historical changes between 2004 and 2005. The community-dwelling sample of the nationally representative Medicare Current Beneficiary Survey ( unweighted unique n= 24 234; response rate, 72.3%) was used, and logistic regression analyses were controlled for demographic characteristics, health status, and historical trends. Main Outcome Measures Self- reports of CRN ( skipping or reducing doses, not obtaining prescriptions) and spending less on basic needs to afford medicines. Results The unadjusted, weighted prevalence of CRN was 15.2% in 2004, 14.1% in 2005, and 11.5% after Part D implementation in 2006. The prevalence of spending less on basic needs was 10.6% in 2004, 11.1% in 2005, and 7.6% in 2006. Adjusted analyses comparing 2006 with 2005 and controlling for historical changes ( 2005 vs 2004) demonstrated significant decreases in the odds of CRN ( ratio of odds ratios [ ORs], 0.85; 95% confidence interval [ CI], 0.74- 0.98; P=. 03) and spending less on basic needs ( ratio of ORs, 0.59; 95% CI, 0.48- 0.72; P <. 001). No significant changes in CRN were observed among beneficiaries with fair to poor health ( ratio of ORs, 1.00; 95% CI, 0.82- 1.21; P=. 97), despite high baseline CRN prevalence for this group ( 22.2% in 2005) and significant decreases among beneficiaries with good to excellent health ( ratio of ORs, 0.77; 95% CI, 0.63- 0.95; P=. 02). However, significant reductions in spending less on basic needs were observed in both groups ( fair to poor health: ratio of ORs, 0.60; 95% CI, 0.47- 0.75; P <. 001; and good to excellent health: ratio of ORs, 0.57; 95% CI, 0.44- 0.75; P <. 001). Conclusions In this survey population, there was evidence for a small but significant overall decrease in CRN and forgoing basic needs following Part D implementation. However, no net decrease in CRN after Part D was observed among the sickest beneficiaries, who continued to experience higher rates of CRN.
引用
收藏
页码:1922 / 1928
页数:7
相关论文
共 47 条
[1]   Use of antihypertensive drugs by Medicare enrollees: Does type of drug coverage matter? [J].
Adams, AS ;
Soumerai, SB ;
Ross-Degnan, D .
HEALTH AFFAIRS, 2001, 20 (01) :276-286
[2]   The case for a Medicare drug coverage benefit: A critical review of the empirical evidence [J].
Adams, AS ;
Soumerai, SB ;
Ross-Degnan, D .
ANNUAL REVIEW OF PUBLIC HEALTH, 2001, 22 :49-61
[3]  
[Anonymous], 2003, MODEL ASSISTED SURVE
[4]   Drug coverage and drug purchases by medicare beneficiaries with hypertension [J].
Blustein, J .
HEALTH AFFAIRS, 2000, 19 (02) :219-230
[5]  
BREISACHER B, MED DISABLED BENEFIC
[6]   Medicare beneficiaries and the impact of gaining prescription drug coverage on inpatient and physician spending [J].
Briesacher, BA ;
Stuart, B ;
Ren, XQ ;
Doshi, JA ;
Wrobel, MV .
HEALTH SERVICES RESEARCH, 2005, 40 (05) :1279-1296
[7]   Patients at-risk for cost-related medication nonadherence: A review of the literature [J].
Briesacher, Becky A. ;
Gurwitz, Jerry H. ;
Soumerai, Stephen B. .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2007, 22 (06) :864-871
[8]  
*C US, 2006, AN PRES BUDG PROP FI
[9]   Pharmaceutical manufacturer assistance programs [J].
Chisholm, MA ;
DiPiro, JT .
ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (07) :780-784
[10]  
CRIPPEN DL, 2002, PROJECTIONS MED PRES